SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to […]
Achieved First-ever Quarterly Adjusted Corporate EBITDA1Profitability Generated Highest-ever Adjusted Store EBITDA Margin of 10.3% SHANGHAI and NEW YORK, Aug. 29, […]
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today […]